Enzo Biochem: Fiscal Q3 Earnings Snapshot
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 16 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Company Financial Performance: Enzo Biochem Inc. reported a loss of $2.8 million in its fiscal third quarter, translating to a loss of 5 cents per share, with adjusted losses at 4 cents per share.
Revenue Details: The biotechnology company generated revenue of $6.4 million during the same period.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
